MiR-223 can mitigate neuroinflammation by regulating Atg16L1, emphasizing Atg16l1’s role in controlling autophagy and inflammation in AD individuals (Li Y. et al., 2019). The gene discussed is ATG16L1; the disease is Alzheimer disease.